Carbohydrate-deficient glycoprotein syndromes

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Four types of carbohydrate-deficient glycoprotein syndromes (CDG) are known, with genetic causes identified for two.
• CDG syndromes present with diverse symptoms varying by age and type.
• Pathology often involves cerebellar and brainstem atrophy, with biochemical deficiencies varying across types.

Purpose of the Study:

• To describe the symptoms, signs, and pathology of carbohydrate-deficient glycoprotein syndromes.
• To outline diagnostic approaches, including clinical features and biochemical tests.
• To discuss the prognosis and management strategies for affected individuals.

Main Methods:

• Clinical observation and description of symptoms and signs across different age groups.
• Genetic mapping of the responsible gene for CDG type Ia to chromosome 16p.
• Biochemical analyses including chromatographic carbohydrate-deficient transferrin assay and isoelectric focusing of serum transferrin.

Main Results:

• CDG type Ia, the most common form, exhibits autosomal recessive inheritance.
• Typical pathology includes atrophy of the cerebellum and brainstem, sometimes extending to the cortex.
• Diagnostic methods rely on clinical recognition and specific biochemical tests for transferrin abnormalities.

Conclusions:

• Diagnosis of CDG requires integrating clinical findings with biochemical test results.
• Prognosis is influenced by complications (renal, hepatic, cardiac), with affected children facing severe handicaps.
• Management focuses on supportive care and managing complications; oral mannose shows efficacy in CDG type Ib.